170 related articles for article (PubMed ID: 28831599)
1. Efficacy of intermediate-dose cytarabine in central nervous system-relapsed wild-type BRAF Erdheim-Chester disease.
Cao XX; Niu N; Sun J; Zhou DB; Li J
Ann Hematol; 2018 Jan; 97(1):185-187. PubMed ID: 28831599
[No Abstract] [Full Text] [Related]
2. Langerhans cell histiocytosis and Erdheim-Chester disease overlap syndrome with bone marrow involvement and type 2 diabetes mellitus.
Chen M; Ding C; Lu T; Niu N; Han B
Ann Hematol; 2018 Jan; 97(1):189-192. PubMed ID: 28889238
[No Abstract] [Full Text] [Related]
3. Efficacy of the MEK inhibitor cobimetinib for wild-type BRAF Erdheim-Chester disease.
Cohen Aubart F; Emile JF; Maksud P; Galanaud D; Cluzel P; Benameur N; Aumaitre O; Amoura Z; Haroche J
Br J Haematol; 2018 Jan; 180(1):150-153. PubMed ID: 27711968
[No Abstract] [Full Text] [Related]
4. Advances in Understanding and Management of Erdheim-Chester Disease.
Kulkarni AM; Gayam PKR; Aranjani JM
Life Sci; 2024 Jul; 348():122692. PubMed ID: 38710283
[TBL] [Abstract][Full Text] [Related]
5. Clinical and positron emission tomography responses to long-term high-dose interferon-α treatment among patients with Erdheim-Chester disease.
Cao XX; Niu N; Sun J; Cai H; Wang FD; Wang YN; Duan MH; Zhou DB; Li J
Orphanet J Rare Dis; 2019 Jan; 14(1):11. PubMed ID: 30630516
[TBL] [Abstract][Full Text] [Related]
6. Erdheim-Chester disease.
Haroche J; Arnaud L; Cohen-Aubart F; Hervier B; Charlotte F; Emile JF; Amoura Z
Rheum Dis Clin North Am; 2013 May; 39(2):299-311. PubMed ID: 23597965
[TBL] [Abstract][Full Text] [Related]
7. Hypoalphalipoproteinemia and BRAF
Cohen-Aubart F; Guerin M; Poupel L; Cluzel P; Saint-Charles F; Charlotte F; Arsafi Y; Emile JF; Frisdal E; Le Goff C; Donadieu J; Amoura Z; Lesnik P; Haroche J; Le Goff W
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1913-1925. PubMed ID: 29930009
[TBL] [Abstract][Full Text] [Related]
8. Erdheim-Chester disease harboring the BRAF V600E mutation.
Blombery P; Wong SQ; Lade S; Prince HM
J Clin Oncol; 2012 Nov; 30(32):e331-2. PubMed ID: 23008323
[No Abstract] [Full Text] [Related]
9. Effective High-dose Interferon-α Therapy in a 13-Year-Old Girl With Erdheim-Chester Disease.
Tezol O; Citak EC; Ayhan YS; Balci Y; Koc ZP; Yuyucu Karabulut Y
J Pediatr Hematol Oncol; 2020 May; 42(4):326-331. PubMed ID: 31259822
[TBL] [Abstract][Full Text] [Related]
10. [Erdheim-Chester disease].
Mazor RD; Shoenfeld Y
Harefuah; 2014 Jul; 153(7):389-91, 434, 433. PubMed ID: 25189027
[TBL] [Abstract][Full Text] [Related]
11. Erdheim-Chester disease.
Campochiaro C; Tomelleri A; Cavalli G; Berti A; Dagna L
Eur J Intern Med; 2015 May; 26(4):223-9. PubMed ID: 25865950
[TBL] [Abstract][Full Text] [Related]
12. A case of Erdheim-Chester disease with spinal cord compression and sphenoid sinus involvement.
Bunaux K; Sevestre H; Emile JF; Capel C; Chenin L; Peltier J
Neurochirurgie; 2018 Dec; 64(6):439-441. PubMed ID: 30274919
[TBL] [Abstract][Full Text] [Related]
13. The histiocytosis Erdheim-Chester disease is an inflammatory myeloid neoplasm.
Haroche J; Cohen-Aubart F; Charlotte F; Maksud P; Grenier PA; Cluzel P; Mathian A; Emile JF; Amoura Z
Expert Rev Clin Immunol; 2015; 11(9):1033-42. PubMed ID: 26197238
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of clinicopathologic characteristics and the BRAF V600E mutation in Erdheim-Chester disease among Chinese adults.
Cao XX; Sun J; Li J; Zhong DR; Niu N; Duan MH; Liang ZY; Zhou DB
Ann Hematol; 2016 Apr; 95(5):745-50. PubMed ID: 26858028
[TBL] [Abstract][Full Text] [Related]
15. [Erdheim-Chester disease (ECD), an inflammatory myeloid neoplasia].
Haroche J; Papo M; Cohen-Aubart F; Charlotte F; Maksud P; Grenier PA; Cluzel P; Mathian A; Emile JF; Amoura Z
Presse Med; 2017 Jan; 46(1):96-106. PubMed ID: 27234902
[TBL] [Abstract][Full Text] [Related]
16. Erdheim-Chester Disease with Emperipolesis: A Unique Case Involving the Heart.
Zhu P; Li N; Yu L; Miranda MN; Wang G; Duan Y
Cancer Res Treat; 2017 Apr; 49(2):553-558. PubMed ID: 27488869
[TBL] [Abstract][Full Text] [Related]
17. Erdheim-Chester Disease With Cardiovascular Involvement and BRAF V600E Mutation.
Okamura K; Suematsu Y; Morizumi S; Kawata M; Dai Y; Yamakawa M; Ono M
Circ J; 2016 Jun; 80(7):1657-9. PubMed ID: 27296272
[No Abstract] [Full Text] [Related]
18. Successful treatment of central nervous system involved Erdheim-Chester disease by intermediate-dose cytarabine as first-line therapy.
Wang JN; Qiu Y; Niu N; Zhang Y; Li J; Zhou DB; Cao XX
Acta Oncol; 2020 Mar; 59(3):302-305. PubMed ID: 31559889
[No Abstract] [Full Text] [Related]
19. Cladribine treatment for Erdheim-Chester disease involving the central nervous system and concomitant polycythemia vera: A case report.
Tamura S; Kawamoto K; Miyoshi H; Suzuki T; Katagiri T; Kasami T; Nemoto H; Miyakoshi S; Kobayashi H; Shibasaki Y; Masuko M; Takeuchi K; Ohshima K; Sone H; Takizawa J
J Clin Exp Hematop; 2018 Dec; 58(4):161-165. PubMed ID: 30305475
[TBL] [Abstract][Full Text] [Related]
20. [Erdheim-Chester disease with meningeal involvement: A case report].
Ortega Zufiría JM; Choque Cuba B; Poveda Núñez P; Tamarit Degenhardt M
Neurocirugia (Astur); 2017; 28(3):157-158. PubMed ID: 28040388
[No Abstract] [Full Text] [Related]
[Next] [New Search]